Avita Medical Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $15.4
- Today's High:
- $16
- Open Price:
- $15.76
- 52W Low:
- $4.41
- 52W High:
- $21.7
- Prev. Close:
- $15.98
- Volume:
- 101462
Company Statistics
- Market Cap.:
- $415.30 million
- Book Value:
- 0.54
- Revenue TTM:
- $40.85 million
- Operating Margin TTM:
- -80.12%
- Gross Profit TTM:
- $28.38 million
- Profit Margin:
- -74.77%
- Return on Assets TTM:
- -21.65%
- Return on Equity TTM:
- -37.9%
Company Profile
Avita Medical Ltd had its IPO on 2019-10-01 under the ticker symbol RCEL.
The company operates in the Healthcare sector and Medical Devices industry. Avita Medical Ltd has a staff strength of 126 employees.
Stock update
Shares of Avita Medical Ltd opened at $15.76 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $15.4 - $16, and closed at $15.58.
This is a -2.5% slip from the previous day's closing price.
A total volume of 101,462 shares were traded at the close of the day’s session.
In the last one week, shares of Avita Medical Ltd have slipped by -4.42%.
Avita Medical Ltd's Key Ratios
Avita Medical Ltd has a market cap of $415.30 million, indicating a price to book ratio of 2.0995 and a price to sales ratio of 6.634.
In the last 12-months Avita Medical Ltd’s revenue was $40.85 million with a gross profit of $28.38 million and an EBITDA of $-32179000. The EBITDA ratio measures Avita Medical Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Avita Medical Ltd’s operating margin was -80.12% while its return on assets stood at -21.65% with a return of equity of -37.9%.
In Q2, Avita Medical Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 41%.
Avita Medical Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.22 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avita Medical Ltd’s profitability.
Avita Medical Ltd stock is trading at a EV to sales ratio of 3.2597 and a EV to EBITDA ratio of -4.7142. Its price to sales ratio in the trailing 12-months stood at 6.634.
Avita Medical Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $86.33 million
- Total Liabilities
- $13.81 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $304000
- Dividend Payout Ratio
- 0%
Avita Medical Ltd ended 2024 with $86.33 million in total assets and $0 in total liabilities. Its intangible assets were valued at $86.33 million while shareholder equity stood at $68.65 million.
Avita Medical Ltd ended 2024 with $0 in deferred long-term liabilities, $13.81 million in other current liabilities, 3000.00 in common stock, $-282192000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $37.49 million and cash and short-term investments were $66.05 million. The company’s total short-term debt was $656,000 while long-term debt stood at $0.
Avita Medical Ltd’s total current assets stands at $77.50 million while long-term investments were $2.75 million and short-term investments were $28.56 million. Its net receivables were $6.20 million compared to accounts payable of $3.84 million and inventory worth $3.06 million.
In 2024, Avita Medical Ltd's operating cash flow was $0 while its capital expenditure stood at $304000.
Comparatively, Avita Medical Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $15.58
- 52-Week High
- $21.7
- 52-Week Low
- $4.41
- Analyst Target Price
- $27.83
Avita Medical Ltd stock is currently trading at $15.58 per share. It touched a 52-week high of $21.7 and a 52-week low of $21.7. Analysts tracking the stock have a 12-month average target price of $27.83.
Its 50-day moving average was $17.5 and 200-day moving average was $13.1 The short ratio stood at 4.76 indicating a short percent outstanding of 0%.
Around 150.5% of the company’s stock are held by insiders while 2401.1% are held by institutions.
Frequently Asked Questions About Avita Medical Ltd
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.